Validation of Donor Oocytes Semi-automated Vitrification

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 23, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

June 30, 2026

Conditions
VitrificationEgg DonorFertilityAssisted Reproductive Technology
Interventions
DEVICE

Gavi, Merck® (automated vitrification instrument)

"This instrument recently appeared on the market and demonstrated a high effectiveness in terms of processing time and reproducibility for embryo vitrification. To date, no study has analyzed the efficiency of this automated vitrification instrument on oocyte vitrification.~The oocytes will be stored in closed cassettes in liquid nitrogen"

DEVICE

Vitrolife system

The oocytes vitrification will be carried out by an authorized technician according to the manual protocol validated and used routinely.

Trial Locations (1)

63000

RECRUITING

CHU de Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER